SFM
MYGN icon

Systematic Financial Management’s Myriad Genetics MYGN Stock Holding History

Systematic Financial Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,755
Closed -$292K – 373
2020
Q2 		$292K Buy
25,755
+810
+3% +$11.5K 0.02% 389
2020
Q1 		$357K Buy
24,945
+245
+1% +$5.18K 0.02% 256
2019
Q4 		$673K Buy
24,700
+6,430
+35% +$177K 0.03% 228
2019
Q3 		$523K Sell
18,270
-20,115
-52% -$586K 0.02% 375
2019
Q2 		$1.07M Sell
38,385
-1,395
-4% -$39.4K 0.04% 252
2019
Q1 		$1.32M Buy
39,780
+1,270
+3% +$38.7K 0.05% 327
2018
Q4 		$1.12M Buy
38,510
+8,310
+28% +$299K 0.03% 405
2018
Q3 		$1.39M Sell
30,200
-6,890
-19% -$306K 0.03% 400
2018
Q2 		$1.39M Sell
37,090
-8,280
-18% -$280K 0.03% 421
2018
Q1 		$1.34M Buy
45,370
+2,380
+6% +$80.5K 0.03% 472
2017
Q4 		$1.48M Sell
42,990
-3,435
-7% -$116K 0.03% 410
2017
Q3 		$1.68M Sell
46,425
-21,885
-32% -$624K 0.03% 318
2017
Q2 		$1.76M Sell
68,310
-30,910
-31% -$656K 0.03% 399
2017
Q1 		$1.91M Sell
99,220
-1,755
-2% -$31.1K 0.03% 355
2016
Q4 		$1.68M Buy
100,975
+15,305
+18% +$277K 0.03% 479
2016
Q3 		$1.76M Buy
85,670
+33,060
+63% +$839K 0.02% 408
2016
Q2 		$1.61M Buy
+52,610
New +$1.83M 0.02% 472
2015
Q3 		– Sell
-71,283
Closed -$2.42M – 682
2015
Q2 		$2.42M Buy
71,283
+6,912
+11% +$235K 0.02% 526
2015
Q1 		$2.28M Sell
64,371
-4,970
-7% -$178K 0.02% 532
2014
Q4 		$2.36M Buy
69,341
+3,355
+5% +$119K 0.02% 427
2014
Q3 		$2.54M Buy
65,986
+11,185
+20% +$417K 0.02% 399
2014
Q2 		$2.13M Sell
54,801
-3,205
-6% -$119K 0.01% 397
2014
Q1 		$1.98M Sell
58,006
-59,533
-51% -$1.84M 0.01% 418
2013
Q4 		$2.46M Sell
117,539
-2,156,575
-95% -$54.5M 0.02% 375
2013
Q3 		$53.4M Buy
2,274,114
+224,025
+11% +$6.36M 0.42% 78
2013
Q2 		$55.1M Buy
+2,050,089
New +$59.4M 0.47% 70

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Systematic Financial Management's MYGN Position: Q3 2020 in Review

Systematic Financial Management sold out of Myriad Genetics (MYGN) in Q3 2020, closing a stake of 25,755 shares — an estimated $292K sold.

Systematic Financial Management first reported a position in MYGN in Q2 2013 and held it in 26 quarters. The position peaked at $55.1M in Q2 2013. 192 funds tracked by Wall St. Rank hold MYGN as of Q3 2020.

  • Systematic Financial Management reported no remaining Myriad Genetics position as of Q3 2020 after selling out during the quarter.
  • Systematic Financial Management sold 25,755 Myriad Genetics shares in Q3 2020, an estimated $292K.
  • Systematic Financial Management first reported a position in Myriad Genetics in Q2 2013 and held it in 26 quarters.
  • Systematic Financial Management's Myriad Genetics position peaked at $55.1M in Q2 2013.
  • 192 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2020.

Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.